Diplomat Pharmacy, Inc. Income Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Operations and Comprehensive (Loss) Income

In millions of USD; shares in millions, except per-share amounts

	FY2018 12 months to Dec 31, 2018	FY2017 12 months to Dec 31, 2017	FY2016 12 months to Dec 31, 2016	FY2015 12 months to Dec 31, 2015	FY2014 12 months to Dec 31, 2014
Cost of products sold
Net sales
Cost of sales
Gross profit
Selling, general and administrative expenses
Goodwill impairments
Impairments of definite-lived intangible assets
(Loss) income from operations
Other (expense) income:
Interest expense
Equity loss and impairment of non-consolidated entities
Change in fair value of redeemable common shares
Termination of existing stock redemption agreement
Other
Total other expense

(Loss) income before income taxes
Pro Forma Data (Note 2)
Total (Loss) income before income taxes

Net (loss) income
Pro Forma Data (Note 2)
Total net (loss) income

Less net loss attributable to noncontrolling interest
Pro Forma Data (Note 2)
Total less net loss attributable to noncontrolling interest

Net (loss) income attributable to Diplomat Pharmacy, Inc.
Pro Forma Data (Note 2)
Total net (loss) income attributable to Diplomat Pharmacy, Inc.

Net income allocable to preferred shareholders
Pro Forma Data (Note 2)
Total net income allocable to preferred shareholders
Net income allocable to common shareholders
Pro Forma Data (Note 2)
Total net income allocable to common shareholders

Other comprehensive loss, net of tax
Total comprehensive (loss) income
(Loss) income per common share:
Basic (in dollars per share)
Diluted (in dollars per share)
Weighted average common shares outstanding:
Basic (in shares)
Diluted (in shares)
Basic (in dollars per share)
Diluted (in dollars per share)

Comments